Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Yolande Lievens
Profile
Projects
Publications
Activities
Awards & Distinctions
195
Results
2023
Developing time-driven activity-based costing at the national level to support policy recommendations for radiation oncology in Belgium
Noémie Defourny
Sophie Hoozée
Jean-François Daisne
Yolande Lievens
A1
Journal Article
in
JOURNAL OF ACCOUNTING AND PUBLIC POLICY
2023
2022
Application of an ultrasensitive NGS-based blood test for the diagnosis of early-stage lung cancer : sensitivity, a hurdle still difficult to overcome
Malaïka Van der Linden
Bram Van Gaever
Lennart Raman
Karim Vermaelen
Ingel Demedts
Veerle Surmont
Ulrike Himpe
Yolande Lievens
Liesbeth Ferdinande
Franceska Dedeurwaerdere
et al.
A1
Journal Article
in
CANCERS
2022
Completeness of reporting oligometastatic disease characteristics in literature and influence on oligometastatic disease classification using the ESTRO/EORTC nomenclature
Daan Nevens
Aurélien Jongen
Isabelle Kindts
Charlotte Billiet
Pieter Deseyne
Ines Joye
Yolande Lievens
Matthias Guckenberger
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2022
Dose-volume-based evaluation of convolutional neural network-based auto-segmentation of thoracic organs at risk
Noémie Johnston
Jeffrey De Rycke
Yolande Lievens
Marc Van Eijkeren
Jan Aelterman
Eva Vandersmissen
Stephan Ponte
Barbara Vanderstraeten
A2
Journal Article
in
PHYSICS & IMAGING IN RADIATION ONCOLOGY
2022
Health-related quality of life, toxicity and neuro-cognitive functioning : what matters to non-small cell lung cancer patients?
Lotte van der Weijst
Yolande Lievens
Veerle Surmont
Dissertation
2022
Innovation, value and reimbursement in radiation and complex surgical oncology : time to rethink
Josep M. Borras
Julieta Corral
Ajay Aggarwal
Riccardo Audisio
Josep Alfons Espinas
Josep Figueras
Peter Naredi
Dimitra Panteli
Nicolas Pourel
Joan Prades
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2022
Innovation, value and reimbursement in radiation and complex surgical oncology : time to rethink
Josep M. Borras
Julieta Corral
Ajay Aggarwal
Riccardo Audisio
Josep Alfons Espinas
Josep Figueras
Peter Naredi
Dimitra Panteli
Nicolas Pourel
Joan Prades
et al.
A2
Journal Article
in
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
2022
Is clinical research serving the needs of the global cancer burden? An analysis of contemporary global radiation therapy randomized controlled trials
Joanna Dodkins
Wilma M. Hopman
John Connor Wells
Yolande Lievens
R.A. Malik
C.S. Pramesh
Bishal Gyawali
Nazik Hammad
Deborah Mukherji
Richard Sullivan
et al.
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2022
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
Sofia C. Vaz
Judit A. Adam
Roberto C. Delgado Bolton
Pierre Vera
Wouter van Elmpt
Ken Herrmann
Rodney J. Hicks
Yolande Lievens
Andrea Santos
Heiko Schöder
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2022
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0 (vol 49, pg 1386, 2022)
Sofia C. Vaz
Judit A. Adam
Roberto C. Delgado Bolton
Pierre Vera
Wouter van Elmpt
Ken Herrmann
Rodney J. Hicks
Yolande Lievens
Andrea Santos
Heiko Schöder
et al.
Correction
2022
Neurocognitive functioning following lung cancer treatment : the PRO-Long study
Lotte van der Weijst
Yolande Lievens
Veerle Surmont
Wim Schrauwen
A2
Journal Article
in
TECHNICAL INNOVATIONS & PATIENT SUPPORT IN RADIATION ONCOLOGY
2022
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer
Sofia C. Vaz
Judit A. Adam
Roberto C. Delgado Bolton
Pierre Vera
Wouter van Elmpt
Ken Herrmann
Rodney J. Hicks
Yolande Lievens
Andrea Santos
Heiko Schöder
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2022
ProCaLung : peer review in stage III, mediastinal node-positive, non-small-cell lung cancer : how to benchmark clinical practice of nodal target volume definition and delineation in Belgium
Florian Charlier
Thomas Descamps
Yolande Lievens
Xavier Geets
Vincent Remouchamps
Maarten Lambrecht
Luigi Moretti
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2022
Variable and fixed costs in NHS radiotherapy : consequences for increasing hypo fractionation
Katie Spencer
Noemie Defourny
David Tunstall
Viv Cosgrove
Karen Kirkby
Ann Henry
Yolande Lievens
Peter Hall
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2022
What really matters for cancer care : health systems strengthening or technological innovation?
A. Aggarwal
Yolande Lievens
R. Sullivan
E. Nolte
Encyclopedia
2022
2021
Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre
Cedric Peters
Julie Vandewiele
Yolande Lievens
Marc Van Eijkeren
Valerie Fonteyne
Tom Boterberg
Pieter Deseyne
Liv Veldeman
Wilfried De Neve
Christel Monten
et al.
A1
Journal Article
in
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY
2021
Clinical evaluation of deep learning for auto-segmentation of computed tomography (CT) images in radiotherapy for lung cancer
Noémie Johnston
Jeffrey De Rycke
Yolande Lievens
Barbara Vanderstraeten
C3
Conference
2021
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
Nicola Rares Franco
Michela Carlotta Massi
Francesca Ieva
Andrea Manzoni
Anna Maria Paganoni
Paolo Zunino
Liv Veldeman
Piet Ost
Valerie Fonteyne
Christopher J. Talbot
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2021
Global radiotherapy : current status and future directions : white paper
May Abdel-Wahab
Soehartati S. Gondhowiardjo
Arthur Accioly Rosa
Yolande Lievens
Noura El-Haj
Jose Alfredo Polo Rubio
Gregorius Ben Prajogi
Herdis Helgadottir
Eduardo Zubizarreta
Ahmed Meghzifene
et al.
A2
Journal Article
in
JCO GLOBAL ONCOLOGY
2021
Hypofractionated radiotherapy in the real-world setting : an international ESTRO- GIRO survey
D. Rodin
B. Tawk
O. Mohamad
S. Grover
F.Y. Moraes
M.L. Yap
E. Zubizarreta
Yolande Lievens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2021
Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial
Mathieu Spaas
Nora Sundahl
Sylvie Rottey
VIBEKE KRUSE
Daan De Maeseneer
Fréderic Duprez
Piet Dirix
Veerle Surmont
Yolande Lievens
Robin Van den Begin
et al.
C3
Conference
2021
Impact of evaluation-decision form in lung cancer patients receiving stereotactic body radiotherapy
Renée Bultijnck
Axel Van Damme
Frederik Vanhoutte
Elhaseen Elamin
Katrien Vandecasteele
Patrick Berkovic
Marc Van Eijkeren
Yolande Lievens
C3
Conference
2021
Phase 3 randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC (NCT01780675)
José S.A. Belderbos
Dirk K.M. De Ruysscher
Katrien De Jaeger
Friederike Koppe
Maarten L.F. Lambrecht
Yolande Lievens
Edith M.T. Dieleman
Jaap P.M. Jaspers
Jan P. Van Meerbeeck
Fred Ubbels
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2021
Radiotherapy for oligometastatic non-small cell lung cancer : a narrative review
Nora Sundahl
Yolande Lievens
A1
Journal Article
in
TRANSLATIONAL LUNG CANCER RESEARCH
2021
Reaction on the interpretation of the hippocampus avoidance prophylactic cranial irradiation trial in SCLC (NCT01780675)
José S.A. Belderbos
Dirk K.M. De Ruysscher
Katrien De Jaeger
Friederike Koppe
Maarten L.F. Lambrecht
Yolande Lievens
Edith M.T. Dieleman
Jaap P.M. Jaspers
Jan P. Van Meerbeeck
Fred Ubbels
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2021
Real life data on patient-reported outcomes and neuro-cognitive functioning of lung cancer patients : the PRO-long study
Lotte van der Weijst
Veerle Surmont
Wim Schrauwen
Yolande Lievens
A1
Journal Article
in
FRONTIERS IN ONCOLOGY
2021
Role of postoperative radiotherapy in the management for resected NSCLC : decision criteria in clinical routine pre- and post-LungART
Krisztian Süveg
Cecile Le Pechoux
Corinne Faivre-Finn
Paul M. Putora
Dirk De Ruysscher
Joachim Widder
Paul Van Houtte
Esther G.C. Troost
Ben J. Slotman
Sara Ramella
et al.
A1
Journal Article
in
CLINICAL LUNG CANCER
2021
Role of radiotherapy in the management of brain metastases of NSCLC : decision criteria in clinical routine
Markus Glatzer
Corinne Faivre-Finn
Dirk De Ruysscher
Joachim Widder
Paul Van Houtte
Esther G.C. Troost
Ben J. Slotman
Sara Ramella
Christoph Pöttgen
Stephanie T.H. Peeters
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2021
Structure and processes of existing practice in radiotherapy peer review : a systematic review of the literature
P.J. Lewis
L.E. Court
Yolande Lievens
A. Aggarwal
A1
Journal Article
in
CLINICAL ONCOLOGY
2021
The European code of cancer practice
Mark Lawler
Kathy Oliver
Stefan Gijssels
Matti Aapro
Agnese Abolina
Tit Albreht
Sema Erdem
Jan Geissler
Jacek Jassem
Sakari Karjalainen
et al.
A2
Journal Article
in
JOURNAL OF CANCER POLICY
2021
Value-based radiotherapy : a new chapter of the ESTRO-HERO project
Yolande Lievens
Josep-Maria Borras
Cai Grau
Ajay Aggarwal
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2021
Why did the randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC not reveal a difference?
José S.A. Belderbos
Dirk K.M. De Ruysscher
Katrien De Jaeger
Friederike Koppe
Maarten L.F. Lambrecht
Yolande Lievens
Edith M.T. Dieleman
Jaap P.M. Jaspers
Jan P. Van Meerbeeck
Fred Ubbels
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2021
2020
Adoption of single-fraction radiotherapy for uncomplicated bone metastases in a tertiary centre
Cedric Peters
Julie Vandewiele
Yolande Lievens
Marc Van Eijkeren
Valerie Fonteyne
Tom Boterberg
Pieter Deseyne
Liv Veldeman
Wilfried De Neve
Christel Monten
et al.
C3
Conference
2020
Characterisation and classification of oligometastatic disease : a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Matthias Guckenberger
Yolande Lievens
Angelique B. Bouma
Laurence Collette
Andre Dekker
Nandita M. deSouza
Anne-Marie C. Dingemans
Beatrice Fournier
Coen Hurkmans
Frédéric E. Lecouvet
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2020
Defining oligometastatic disease from a radiation oncology perspective : an ESTRO-ASTRO consensus document
Yolande Lievens
Matthias Guckenberger
Daniel Gomez
Morten Hoyer
Puneeth Iyengar
Isabelle Kindts
Alejandra Méndez Romero
Daan Nevens
David Palma
Catherine Park
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2020
Detection of copy number alterations by shallow whole-genome sequencing of formalin-fixed, paraffin-embedded tumor tissue
Malaïka Van der Linden
Lennart Raman
Ansel Vander Trappen
Annelies Dheedene
Matthias De Smet
Tom Sante
David Creytens
Yolande Lievens
Björn Menten
Jo Van Dorpe
et al.
A1
Journal Article
in
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
2020
ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer
Cecile Le Pechoux
Corinne Faivre-Finn
Sara Ramella
Fiona McDonald
Farkhad Manapov
Paul Martin Putora
Ben Slotman
Dirk De Ruysscher
Umberto Ricardi
Xavier Geets
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2020
Effect of COVID-19 pandemic on practice in European radiation oncology centers
Berend J. Slotman
Yolande Lievens
Philips Poortmans
Valerie Cremades
Thomas Eichler
Daniel Victor Wakefield
Umberto Ricardi
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2020
European cancer organisation Essential Requirements for Quality Cancer Care (ERQCC) : lung cancer
Thierry Berghmans
Yolande Lievens
Matti Aapro
Anne-Marie Baerd
Marc Beishon
Fiorella Calabrese
Csaba Dégi
Roberto C. Delgado Bolton
Mina Gaga
József Lövey
et al.
A1
Journal Article
in
LUNG CANCER
2020
Feasibility and impact of national peer reviewed clinical audits in radiotherapy departments
Aude Vaandering
Yolande Lievens
Pierre Scalliet
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2020
Health-related quality of life after accelerated breast irradiation in five fractions : a comparison with fifteen fractions
Hans Van Hulle
Vincent Vakaet
Renée Bultijnck
Pieter Deseyne
Max Schoepen
ANNICK VAN GREVELING
Giselle Post
Wilfried De Neve
Christel Monten
Yolande Lievens
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2020
How public health services pay for radiotherapy in Europe : an ESTRO–HERO analysis of reimbursement
Yolande Lievens
Noémie Defourny
Julieta Corral
Chiara Gasparotto
Cai Grau
Josep Maria Borras
ESTRO-HERO Consortium
A1
Journal Article
in
LANCET ONCOLOGY
2020
Initial impact and operational response of radiation oncology practices to the COVID-19 pandemic in the United States, Europe, and Latin America
D.V. Wakefield
T. Sanders
E. Wilson
A. Hubler
T.L. DeWeese
B.D. Smith
T.J. Eichler
B.J. Slotman
Yolande Lievens
P. Poortmans
et al.
C3
Conference
2020
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic : an ESTRO-ASTRO consensus statement q
M Guckenberger
C Belka
A Bezjak
J Bradley
ME Daly
D DeRuysscher
R Dziadziuszko
C Faivre-Finn
M Flentje
E Gore
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2020
Practice recommendations for lung cancer radiotherapy during the covid-19 pandemic : an estro-astro consensus statement
Matthias Guckenberger
Claus Belka
Andrea Bezjak
Jeffrey Bradley
Megan E. Daly
Dirk DeRuysscher
Rafal Dziadziuszko
Corinne Faivre-Finn
Michael Flentje
Elizabeth Gore
et al.
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2020
Provision and use of radiotherapy in Europe
Yolande Lievens
Josep M. Borras
Cai Grau
A1
Journal Article
in
MOLECULAR ONCOLOGY
2020
Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma
Lennart Raman
Malaïka Van der Linden
Kim Van der Eecken
Karim Vermaelen
Ingel Demedts
Veerle Surmont
Ulrike Himpe
Franceska Dedeurwaerdere
Liesbeth Ferdinande
Yolande Lievens
et al.
A1
Journal Article
in
GENOME MEDICINE
2020
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR : a multicentre, randomised controlled open-label phase II trial
Relinde I. Y. Lieverse
Evert J. Van Limbergen
Cary J. G. Oberije
Esther G. C. Troost
Sine R. Hadrup
Anne-Marie C. Dingemans
Lizza E. L. Hendriks
Franziska Eckert
Crispin Hiley
Christophe Dooms
et al.
A1
Journal Article
in
BMC CANCER
2020
The financial impact of SBRT for oligometastatic disease : a population-level analysis in Belgium
Daan Nevens
Isabelle Kindts
Noémie Defourny
Leen Boesmans
Nancy Van Damme
Hilde Engels
Carine Van de Voorde
Yolande Lievens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2020
Une enquête de l’utilisation en Belgique de la radiothérapie pour des affections bénignes, non-tumorales
P. Van Houtte
V. Remouchamps
Yolande Lievens
Belgian College for Physicians in Radiation Oncology
A1
Journal Article
in
CANCER RADIOTHERAPIE
2020
2019
A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)
Carole Mercier
Piet Dirix
Piet Ost
Charlotte Billiet
Ines Joye
Peter Vermeulen
Yolande Lievens
Dirk Verellen
A1
Journal Article
in
BMC CANCER
2019
Accelerating adjuvant breast irradiation in women over 65 years : matched case analysis comparing a 5-fractions schedule with 15 fractions in early and locally advanced breast cancer
Hans Van Hulle
Dieter Naudts
Ellen Deschepper
Vincent Vakaet
Leen Paelinck
Giselle Post
ANNICK VAN GREVELING
Bruno Speleers
Pieter Deseyne
Yolande Lievens
et al.
A1
Journal Article
in
JOURNAL OF GERIATRIC ONCOLOGY
2019
Adapted Delta4 phantom for EBT3 film based pre-treatment QA for lung SBRT VMAT : proof of concept
E. Bogaert
Frederik Vanhoutte
D. Dechambre
Yolande Lievens
Carlos De Wagter
C3
Conference
2019
Bringing Europe together in building clinical evidence for proton therapy – the EPTN–ESTRO–EORTC endeavor
Damien C. Weber
Cai Grau
Pei S. Lim
Dietmar Georg
Yolande Lievens
A1
Journal Article
in
ACTA ONCOLOGICA
2019
Combined modality treatment for malignant pleural mesothelioma : a single-centre long-term survival analysis using extrapleural pneumonectomy
Anna Elisabeth Frick
Kristiaan Nackaerts
Johnny Moons
Yolande Lievens
Eric Verbeken
Maarten Lambrecht
Johan Coolen
Christophe Dooms
Johan Vansteenkiste
Paul De Leyn
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
2019
Critical review and quality-assessment of cost analyses in radiotherapy : how reliable are the data?
Noémie Defourny
Christel Monten
Cai Grau
Yolande Lievens
Lionel Perrier
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2019
Definition of synchronous oligometastatic non–small cell lung cancer : a consensus report
Anne-Marie C. Dingemans
Lizza E.L. Hendriks
Thierry Berghmans
Antonin Levy
Baktiar Hasan
Corinne Faivre-Finn
Matteo Giaj-Levra
Niccolò Giaj-Levra
Nicolas Girard
Laurent Greillier
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2019
ESMO-MCBS : setting the record straight : authors' reply
Yolande Lievens
Riccardo Audisio
Ian Banks
Laurence Collette
Cai Grau
Kathy Oliver
Richard Price
Ajay Aggarwal
A1
Journal Article
in
LANCET ONCOLOGY
2019
Health-related quality of life in advanced non-small cell lung cancer : a methodological appraisal based on a systematic literature review
Lotte van der Weijst
Yolande Lievens
Wim Schrauwen
Veerle Surmont
A1
Journal Article
in
FRONTIERS IN ONCOLOGY
2019
Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer
Rudi Apolle
Steffen Appold
Henk P. Bijl
Pierre Blanchard
Johan Bussink
Corinne Faivre-Finn
Jonathan Khalifa
Anne Laprie
Yolande Lievens
Indira Madani
et al.
A1
Journal Article
in
ACTA ONCOLOGICA
2019
Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation
F Bartel
M van Herk
H Vrenken
F Vandaele
S Sunaert
K de Jaeger
NJ Dollekamp
C Carbaat
E Lamers
EMT Dieleman
et al.
A1
Journal Article
in
CLINICAL & TRANSLATIONAL ONCOLOGY
2019
Is the combination of immunotherapy and radiotherapy in non-small cell lung cancer a feasible and effective approach?
Mathieu Spaas
Yolande Lievens
A1
Journal Article
in
FRONTIERS IN MEDICINE
2019
Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients : evaluation of the added prognostic value for overall survival and locoregional recurrence
Janna E van Timmeren
Wouter van Elmpt
Ralph TH Leijenaar
Bart Reymen
René Monshouwer
Johan Bussink
Leen Paelinck
Evelien Bogaert
Carlos De Wagter
ELHASEEN ELAMIN
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2019
Moonshot or groundshot : addressing Europe's cancer challenge through a patient-focused, data-enabled lens
Mark Lawler
Peter Naredi
Tanja Cufer
Ian Banks
Yolande Lievens
Giles Vassal
Matti Aapro
Maja Južnič Sotlar
Thierry Philip
Jacek Jassem
et al.
Editorial material
2019
National costs and resource requirements of external beam radiotherapy : a time-driven activity-based costing model from the ESTRO-HERO project
Noémie Defourny
Lionel Perrier
Josep-Maria Borras
Mary Coffey
Julietta Corral
Sophie Hoozée
Judith van Loon
Cai Grau
Yolande Lievens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2019
Patient-reported outcomes after stereotactic body radiotherapy in lung cancer: The Lung PLUS study
Lotte van der Weijst
Renée Bultijnck
Axel Van Damme
Marc Van Eijkeren
Veerle Surmont
Yolande Lievens
C3
Conference
2019
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
Petra Seibold
Adam Webb
Miguel E. Aguado-Barrera
David Azria
Celine Bourgier
Muriel Brengues
Erik Briers
Renée Bultijnck
Patricia Calvo-Crespo
Ana Carballo
et al.
A1
Journal Article
in
Radiotherapy and Oncology
2019
Radiation oncology : optimal health for all, together : ESTRO vision, 2030
Yolande Lievens
Umberto Ricardi
Philip Poortmans
Dirk Verellen
Chiara Gasparotto
Christine Verfaillie
Alessandro J. Cortese
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2019
Radiotherapy in Europe : cost-modelling at national level
Noémie Defourny
Yolande Lievens
M Lionel Perrier
Dissertation
2019
Real-world neurocognitive function in lung cancer : initial results of the PRO-Long study.
Lotte van der Weijst
Veerle Surmont
Wim Schrauwen
Yolande Lievens
C3
Conference
2019
Recommendations for the organisation of care in paediatric radiation oncology across Europe : a SIOPE-ESTRO-PROS-CCI-Europe collaborative project in the framework of the JARC
Geert O. Janssens
Beate Timmermann
Anne Laprie
Henry Mandeville
Laetitia Padovani
Cyrus Chargari
Neige Journy
Lejla Kameric
Anita Kienesberger
Melanie Brunhofer
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2019
Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries : a model-based analysis of need and economic impact
Danielle Rodin
Emily A Burger
Rifat Atun
Michael Barton
Mary Gospodarowicz
Surbhi Grover
Timothy P Hanna
David A Jaffray
Felicia M Knaul
Yolande Lievens
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2019
Towards an evidence-informed value scale for surgical and radiation oncology : a multi-stakeholder perspective
Yolande Lievens
Riccardo Audisio
Ian Banks
Laurence Collette
Cai Grau
Kathy Oliver
Richard Price
Ajay Aggarwal
A1
Journal Article
in
LANCET ONCOLOGY
2019
Value-based health care : what does it mean for radiotherapy?
Yolande Lievens
Cai Grau
Ajay Aggarwal
Editorial material
2019
2018
Accelerating adjuvant breast radiotherapy : the cost of convenience
Christel Monten
Yolande Lievens
Liv Veldeman
Rudy Van den Broecke
Dissertation
2018
Adjuvant breast radiotherapy : how to trade-off cost and effectiveness?
Christel Monten
Yolande Lievens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2018
Automated instead of manual treatment planning? : a plan comparison based on dose-volume statistics and clinical preference
Barbara Vanderstraeten
BRUNO GODDEERIS
Katrien Vandecasteele
Marc Van Eijkeren
Carlos De Wagter
Yolande Lievens
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2018
Changing the global radiation therapy paradigm
David A Pistenmaa
Manjit Dosanjh
Ugo Amaldi
David Jaffray
Eduardo Zubizarreta
Katherine Holt
Yolande Lievens
Yakov Pipman
C Norman Coleman
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2018
Doing the right thing : quality in radiotherapy, a European perspective
A Vaandering
N Jornet
P Scalliet
M Coffey
Yolande Lievens
Editorial material
2018
ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer
Ursula Nestle
Dirk De Ruysscher
Umberto Ricardi
Xavier Geets
Jose Belderbos
Christoph Poettgen
Rafal Dziadiuszko
Stephanie Peeters
Yolande Lievens
Coen Hurkmans
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2018
Economic data for particle therapy : dealing with different needs in a heterogeneous landscape
Yolande Lievens
Klaus Nagels
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2018
Estimating the number of fractions by tumour site for European countries in 2012 and 2025 : an ESTRO-HERO analysis
Josep M Borras
Cai Grau
Julieta Corral
Karen Wong
Michael B Barton
Jacques Ferlay
Freddie Bray
Yolande Lievens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2018
Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium
Valerie Fonteyne
Elke Rammant
Piet Ost
Yolande Lievens
Bart De Troyer
Sylvie Rottey
Gert De Meerleer
Daan De Maeseneer
Dirk De Ridder
Karel Decaestecker
A1
Journal Article
in
CLINICAL GENITOURINARY CANCER
2018
External partial breast irradiation in prone position : how to improve accuracy?
Christel Monten
Liv Veldeman
Katrien Vandecasteele
Ana Maria Luiza Olteanu
Werner De Gersem
Tom Vercauteren
Thomas Mulliez
Rudy Van den Broecke
Herman Depypere
Wilfried De Neve
et al.
A1
Journal Article
in
ACTA ONCOLOGICA
2018
Practice-changing radiation therapy trials for the treatment of cancer : where are we 150 years after the birth of Marie Curie?
Mareike K Thompson
Philip Poortmans
Anthony J Chalmers
Corinne Faivre-Finn
Emma Hall
Robert A Huddart
Yolande Lievens
David Sebag-Montefiore
Charlotte E Coles
A1
Journal Article
in
BRITISH JOURNAL OF CANCER
2018
Prospective data registration and clinical trials for particle therapy in Europe
Johannes A Langendijk
Roberto Orecchia
Karin Haustermans
Daniel Zips
Jacques Balosso
Denis Lacombe
Yolande Lievens
Damien C Weber
Cai Grau
Esher GC Troost
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2018
Radiation therapy quality assurance (RTQA) of concurrent chemoradiation therapy for locally advanced non-small cell lung cancer in the PROCLAIM Phase 3 trial
Anthony M Brade
Frederik Wenz
Friederike Koppe
Yolande Lievens
Belen San Antonio
Neill A Iscoe
Anwar Hossain
Nadia Chouaki
Suresh Senan
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2018
Radiation therapy research : a global analysis 2001-2015
Ajay Aggarwal
Grant Lewison
Danielle Rodin
Anthony Zietman
Richard Sullivan
Yolande Lievens
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2018
The current place of radiotherapy as treatment option for muscle-invasive bladder cancer
Elke Rammant
Karel Decaestecker
Yolande Lievens
P. Dirix
P. Sargos
M. Vedang
L. Eapen
J. Christodouleas
Valerie Fonteyne
[ missing ] on behalf of IBIS group
C3
Conference
2018
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer : a consensus recommendation from the EORTC Imaging Group
Frederic E Lecouvet
Daniela E Oprea-Lager
Yan Liu
Piet Ost
Luc Bidaut
Laurence Collette
Christophe M Deroose
Karolien Goffin
Ken Herrmann
Otto S Hoekstra
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2018
2017
A critical quality appraisal of studies estimating the cost of radiotherapy
Noémie Defourny
Yolande Lievens
P Dunscombe
J Monnet
C Grau
L Perrier
C3
Conference
2017
A systematic review of health economic evaluation in adjuvant breast radiotherapy : quality counted by numbers
Christel Monten
Liv Veldeman
Nick Verhaeghe
Yolande Lievens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2017
Access to innovative radiotherapy : how to make it happen from an economic perspective?
Yolande Lievens
Editorial material
2017
Adaptive radiotherapy for locally advanced non-small cell lung cancer : dosimetric gain and treatment outcome prediction
PATRICK BERKOVIC
Leen Paelinck
Akos Gulyban
Marc Van Eijkeren
Veerle Surmont
Yolande Lievens
Katrien Vandecasteele
A1
Journal Article
in
ACTA ONCOLOGICA
2017
Analysis of global radiotherapy needs and costs by geographic region and income level
E Zubizarreta
J Van Dyk
Yolande Lievens
A1
Journal Article
in
CLINICAL ONCOLOGY
2017
Balancing equity and advancement : the role of health technology assessment in radiotherapy resource allocation
D Rodin
A Aggarwal
Yolande Lievens
R Sullivan
A1
Journal Article
in
CLINICAL ONCOLOGY
2017
Cost evaluation to optimise radiation therapy implementation in different income settings : a time-driven activity-based analysis
Jacob Van Dyk
Eduardo Zubizarreta
Yolande Lievens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2017
Global impact of radiotherapy in oncology : saving one million lives by 2035
Yolande Lievens
Mary Gospodarowicz
Surbhi Grover
David Jaffray
Danielle Rodin
Julie Torode
Mei Ling Yap
Eduardo Zubizarreta
Editorial material
2017
Health-related quality of life reporting in lung cancer trials : a methodological appraisal
Lotte van der Weijst
Veerle Surmont
Wim Schrauwen
Yolande Lievens
C3
Conference
2017
Highly accelerated irradiation in 5 fractions (HAI-5) : feasibility in elderly women with early or locally advanced breast cancer
Christel Monten
Yolande Lievens
Ana Maria Luiza Olteanu
Leen Paelinck
Bruno Speleers
Pieter Deseyne
Rudy Van den Broecke
Wilfried De Neve
Liv Veldeman
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2017
Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma : on behalf of the Radiotherapy Committee of the EORTC lymphoma group
Marianne C Aznar
Theodore Girinsky
Anne Kiil Berthelsen
Berthe Aleman
Max Beijert
Martin Hutchings
Yolande Lievens
Paul Meijnders
Peter Meidahl Petersen
Deborah Schut
et al.
A1
Journal Article
in
ACTA ONCOLOGICA
2017
Radiotherapy access in Belgium : how far are we from evidence-based utilisation?
Yolande Lievens
H De Schutter
K Stellamans
M Rosskamp
L Van Eycken
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2017
Radiotherapy quality assurance of concurrent chemoradiotherapy in PROCLAIM phase III trial
Anthony Brade
Frederik Wenz
Friederike Koppe
Yolande Lievens
Belen San Antonio
Neill Iscoe
Anwar Hossain
Nadia Chouaki
Suresh Senan
C3
Conference
2017
Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer : has it yet become state-of-the-art?
Lotte van der Weijst
Veerle Surmont
Wim Schrauwen
Yolande Lievens
A1
Journal Article
in
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2017
Tumor regression gradient predicts disease free survival
Patrick Berkovic
Leen Paelinck
Katrien Vandecasteele
Akos Gulyban
Carlos De Wagter
BRUNO GODDEERIS
Yolande Lievens
C3
Conference
2017
2016
Automated instead of manual planning for lung SBRT? A plan comparison based on dose-volume statistics
Barbara Vanderstraeten
BRUNO GODDEERIS
CRISTINA DERIE
Katrien Vandecasteele
Marc Van Eijkeren
Leen Paelinck
Carlos De Wagter
Yolande Lievens
C3
Conference
2016
Besoins et financement de la radiothérapie en France et en Europe
Noémie Defourny
Yolande Lievens
A1
Journal Article
in
CANCER RADIOTHERAPIE
2016
Cost evaluations of radiotherapy: what do we know? : an ESTRO-HERO analysis
Noémie Defourny
Peter Dunscombe
Lionel Perrier
Cai Grau
Yolande Lievens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2016
Dual registration for optimal cone beam computed tomography registration for locally advanced cervix carcinoma
Evelien Bogaert
LUDWIG VAN DEN BERGHE
ANNE-LEEN MICHIELS
Carlos De Wagter
Yolande Lievens
Katrien Vandecasteele
C3
Conference
2016
Global access to radiation therapy for cervical cancer : the cost of inaction
D Rodin
TP Hanna
E Burger
E Zubizarreta
ML Yap
MB Barton
R Atun
F Knaul
J Van Dyk
Yolande Lievens
et al.
C3
Conference
2016
How many new cancer patients in Europe will require radiotherapy by 2025? : an ESTRO-HERO analysis
Josep M Borras
Yolande Lievens
Michael Barton
Julieta Corral
Jacques Ferlay
Freddie Bray
Cai Grau
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2016
Interobserver delineation uncertainty in involved node therapy for early-stage Hodgkin lymphoma
MC Aznar
MV Maraldo
T Girinski
A Kiil Berthelsen
B Aleman
M Beijert
M Hutchings
Yolande Lievens
PJ Meijnders
PM Petersen
et al.
C3
Conference
2016
Quality of life in locally-advanced non-small cell lung cancer patients : a systematic review
Lotte van der Weijst
Wim Schrauwen
Veerle Surmont
Yolande Lievens
C3
Conference
2016
Treatment time in breast irradiation : a trade-off between positioning and complexity
Christel Monten
Liv Veldeman
Yolande Lievens
C3
Conference
2016
2015
Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?
PATRICK BERKOVIC
Leen Paelinck
Yolande Lievens
Akos Gulyban
BRUNO GODDEERIS
CRISTINA DERIE
Veerle Surmont
Wilfried De Neve
Katrien Vandecasteele
A1
Journal Article
in
ACTA ONCOLOGICA
2015
Assessing the gap between evidence based indications for radiotherapy and actual practice in European countries
JM Borras
P Dunscombe
M Barton
C Gasparotto
Noémie Defourny
C Grau
Yolande Lievens
C3
Conference
2015
Automated planning for lung SBRT: faster optimization without compromise on plan quality
BRUNO GODDEERIS
Barbara Vanderstraeten
Katrien Vandecasteele
Marc Van Eijkeren
CRISTINA DERIE
Carlos De Wagter
Yolande Lievens
C3
Conference
2015
Clinical implementation of an EPID based in vivo dosimetry system
NINA DE KERPEL
NIKI DE MAESENEIRE
Tom Vercauteren
Frederik Decoster
Yolande Lievens
Carlos De Wagter
C3
Conference
2015
Cost calculation: a necessary step towards widespread adoption of advanced radiotherapy technology
Yolande Lievens
Jose Maria Borras
Cai Grau
A1
Journal Article
in
ACTA ONCOLOGICA
2015
Expanding global access to radiotherapy
Rifat Atun
David A Jaffray
Michael B Barton
Freddie Bray
Michael Baumann
Bhadrasain Vikram
Timothy P Hanna
Felicia M Knaul
Yolande Lievens
Tracey YM Lui
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2015
Expanding global access to radiotherapy: the European Society for Radiotherapy and Oncology perspective
Philip Poortmans
Vincenzo Valentini
Yolande Lievens
Editorial material
2015
Exploiting the asymmetric layer geometry of EBT2 radiochromic film for assessment of skin dose and steep gradients
Carlos De Wagter
NIKI DE MAESENEIRE
Nathalie Goethals
Annemieke De Puysseleyr
Wilfried De Neve
Yolande Lievens
C3
Conference
2015
G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
Lies Pottel
Michelle Lycke
Tom Boterberg
Hans Pottel
Laurence Goethals
Fréderic Duprez
Sylvie Rottey
Yolande Lievens
Nele Van Den Noortgate
Kurt Geldhof
et al.
A1
Journal Article
in
BMC CANCER
2015
Global task force on radiotherapy for cancer control
David A Jaffray
Felicia M Knaul
Rifat Atun
Cary Adams
Michael B Barton
Michael Baumann
Yolande Lievens
Tracey YM Lui
Danielle L Rodin
Eduardo Rosenblatt
et al.
Editorial material
2015
HERO (Health Economics in Radiation Oncology) : a Pan-European project on radiotherapy resources and needs
Yolande Lievens
P Dunscombe
Noémie Defourny
C Gasparotto
JM Borras
C Grau
A1
Journal Article
in
CLINICAL ONCOLOGY
2015
Heart dose reduction by prone deep inspiration breath hold in left-sided breast irradiation
Thomas Mulliez
Liv Veldeman
Bruno Speleers
Khalil Mahjoubi
Vincent Remouchamps
ANNICK VAN GREVELING
Monique Gilsoul
Dieter Berwouts
Yolande Lievens
Rudy Van den Broecke
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2015
Implementation and clinical evaluation of automated planning for IMRT treatment of breast cancer
Barbara Vanderstraeten
Liv Veldeman
RAF DHONDT
Carlos De Wagter
Yolande Lievens
C3
Conference
2015
Influence of the grid size on the dosimetric characteristics of IMRT beams and on overall treatment plans
GEERT PITTOMVILS
Ana Maria Luiza Olteanu
Barbara Vanderstraeten
Carlos De Wagter
Yolande Lievens
C3
Conference
2015
Prone breast irradiation: from indirect to direct tumor bed localization
Christel Monten
Ana Maria Luiza Olteanu
Tom Vercauteren
Liv Veldeman
ANNICK VAN GREVELING
Rudy Van den Broecke
Wilfried De Neve
Bruno Speleers
Yolande Lievens
C3
Conference
2015
Radiation therapy and the global health agenda
DA Jaffray
R Atun
M Barton
M Baumann
M Gospodarowicz
P Hoskin
FM Knaul
Yolande Lievens
E Rosenblatt
J Torode
et al.
Editorial material
2015
Responding to the cancer crisis: expanding global access to radiotherapy: a Lancet Oncology Commission
R Atun
D Jaffray
M Barton
M Baumann
B Vikram
F Bray
T Hanna
F Knaul
Yolande Lievens
B O'Sullivan
et al.
C3
Conference
2015
Stereotactic Body Radiotherapy for Lung Cancer How Much Does it Really Cost?
Yolande Lievens
Caroline Obyn
Anne-Sophie Mertens
Dries Van Halewyck
Frank Hulstaert
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2015
The cost of radiotherapy: what do we know? : a systematic search of the literature between 1981 and 2015
Noémie Defourny
L Perrier
P Dunscombe
C Grau
Yolande Lievens
C3
Conference
2015
The impact of cancer incidence and stage on optimal utilization of radiotherapy: methodology of a population based analysis by the ESTRO-HERO project
Josep M Borras
Michael Barton
Cai Grau
Julieta Corral
Rob Verhoeven
Valery Lemmens
Liesbet van Eycken
Kris Henau
Maja Primic-Zakelj
Primoz Strojan
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2015
The need for radiotherapy in Europe in 2020: not only data but also a cancer plan
Josep M Borras
Yolande Lievens
Cai Grau
A1
Journal Article
in
ACTA ONCOLOGICA
2015
The optimal utilization proportion of external beam radiotherapy in European countries : an ESTRO-HERO analysis
Josep M Borras
Yolande Lievens
Peter Dunscombe
Mary Coffey
Julian Malicki
Julieta Corral
Chiara Gasparotto
Noémie Defourny
Michael Barton
Rob Verhoeven
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2015
Unresectable stage III non-small-cell lung cancer : have we made any progress?
CAROLIEN DE TOLLENAERE
Yolande Lievens
Katrien Vandecasteele
Karim Vermaelen
Veerle Surmont
A2
Journal Article
in
WORLD JOURNAL OF RESPIROLOGY
2015
2014
Adaptive intensity-modulated radiation therapy for head and neck cancer: is it affordable?
Barbara Vanderstraeten
Dieter Berwouts
BRUNO GODDEERIS
Fréderic Duprez
Wilfried De Neve
Yolande Lievens
C3
Conference
2014
Budget impact vs cost effectiveness: implications for personalised cancer therapies
Yolande Lievens
C3
Conference
2014
EGFR mutation positive stage IV non small-cell lung cancer: treatment beyond progression
KATRIJN VAN ASSCHE
Liesbeth Ferdinande
Yolande Lievens
Katrien Vandecasteele
Veerle Surmont
A2
Journal Article
in
FRONTIERS IN ONCOLOGY
2014
From supine to prone breast radiotherapy: an unaffordable cost?
LUDWIG VAN DEN BERGHE
Barbara Vanderstraeten
Liv Veldeman
NATHALIE FLAMEE
Yolande Lievens
C3
Conference
2014
Guidelines for equipment and staffing of radiotherapy facilities in the European countries : final results of the ESTRO-HERO survey
Peter Dunscombe
Cai Grau
Noémie Defourny
Julian Malicki
Josep M Borras
Mary Coffey
Marta Bogusz
Chiara Gasparotto
Ben Slotman
Yolande Lievens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2014
In search of the economic sustainability of hadron therapy: the real cost of setting up and operating a hadron facility
Barbara Vanderstraeten
Jan Verstraete
Roger De Croock
Wilfried De Neve
Yolande Lievens
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2014
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial
John MM Raemaekers
Marc PE Andre
Massimo Federico
Theodore Girinsky
Reman Oumedaly
Ercole Brusamolino
Pauline Brice
Christophe Ferme
Richard van der Maazen
Manuel Gotti
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2014
Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey
Cai Grau
Noémie Defourny
Julian Malicki
Peter Dunscombe
Josep M Borras
Mary Coffey
Ben Slotman
Marta Bogusz
Chiara Gasparotto
Yolande Lievens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2014
Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey
Yolande Lievens
Noémie Defourny
Mary Coffey
Josep M Borras
Peter Dunscombe
Ben Slotman
Julian Malicki
Marta Bogusz
Chiara Gasparotto
Cai Grau
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2014
The cost of setting up and operating a hadron facility: reply
Barbara Vanderstraeten
Wilfried De Neve
Yolande Lievens
Jan Verstraete
Roger De Croock
Editorial material
2014
2013
Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients
Georgi Nalbantov
Bas Kietselaer
Katrien Vandecasteele
Cary Oberije
Maaike Berbee
Esther Troost
Anne-Marie Dingemans
Angela van Baardwijk
Kim Smits
André Dekker
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2013
Cost calculation of hadron therapy in Belgium: a physics point of view
Barbara Vanderstraeten
Jan Verstraete
Roger De Croock
Wilfried De Neve
Yolande Lievens
C3
Conference
2013
Feasibility study of a Hadron Therapy Centre in Belgium
Lieven Annemans
Francis Colardyn
Roger De Croock
Wilfried De Neve
Fréderic Duprez
Akos Gulyban
Kris Henau
Yolande Lievens
Indira Madani
Piet Ost
et al.
Report
2013
Health economic controversy and cost-effectiveness of proton therapy
Yolande Lievens
Madelon Pijls-Johannesma
A1
Journal Article
in
SEMINARS IN RADIATION ONCOLOGY
2013
Modeling the standard Elekta linear accelerator table top in a treatment planning system
Leen Paelinck
Barbara Vanderstraeten
Yolande Lievens
Carlos De Wagter
C3
Conference
2013
Pathologic complete remission of malignant pleural mesothelioma after combined modality treatment : a case report
K Moubax
V Van Damme
P Nafteux
M Van den Heuvel
E Verbeken
Yolande Lievens
K Nackaerts
A1
Journal Article
in
ACTA CLINICA BELGICA
2013
Proton radiotherapy for locally-advanced non-small cell lung cancer, a cost-effective alternative to photon radiotherapy in Belgium?
Yolande Lievens
Nick Verhaeghe
Wilfried De Neve
Indira Madani
Barbara Vanderstraeten
Jan Verstraete
Lieven Annemans
C3
Conference
2013
Radiotherapy capacity in Europe
Cai Grau
Josep M Borras
Julian Malicki
Ben Slotman
Peter Dunscombe
Mary Coffey
Donal Hollywood
Ferran Guedea
Chiara Gasparotto
Yolande Lievens
A1
Journal Article
in
LANCET ONCOLOGY
2013
Technology assessment, outcome analysis research, comparative effectiveness, and evidence-based radiation oncology
Carlos A Perez
Edward C Halperin
Yolande Lievens
Bookchapter
in
Perez and Brady's principles and practice of radiation oncology
2013
The cost of hadron therapy in Belgium: comparison of a business model with activity-based costing
Barbara Vanderstraeten
Jan Verstraete
Roger De Croock
Wilfried De Neve
Yolande Lievens
C3
Conference
2013
2012
Changes in pulmonary function up to 10 years after locoregional breast irradiation
Katrien Erven
Caroline Weltens
Kristiaan Nackaerts
Steffen Fieuws
Marc Decramer
Yolande Lievens
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2012
Health economics in radiation oncology: introducing the ESTRO HERO project
Yolande Lievens
Cai Grau
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2012
The cost of radiotherapy in a decade of technology evolution
Evelyn Van de Werf
Jan Verstraete
Yolande Lievens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2012
2011
Hypofractionation in breast radiotherapy: a dominant situation?
Yolande Lievens
A1
Journal Article
in
BREAST
2011
Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study
Yolande Lievens
An Nulens
Mousa Amr Gaber
Gilles Defraene
Walter De Wever
Sigrid Stroobants
Frank Van den Heuvel
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2011
2010
A systematic methodology review of phase I radiation dose escalation trials
Madelon Pijls-Johannesma
Ghislaine van Mastrigt
Steve M Hahn
Dirk De Ruysscher
Brigitta G Baumert
Guido Lammering
Jerone Buijsen
Soren M Bentzen
Yolande Lievens
Andrew Kramar
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2010
Hypofractionated breast radiotherapy: financial and economic consequences
Yolande Lievens
A1
Journal Article
in
BREAST
2010
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
RA Stahel
W Weder
Yolande Lievens
E Felip
A1
Journal Article
in
ANNALS OF ONCOLOGY
2010
Radiotherapy in early stage Hodgkin's lymphoma: the importance of volume and treatment position
Bart Reymen
Sylvie Spiessens
Yolande Lievens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2010
Simulating demand for innovative radiotherapies: an illustrative model based on carbon ion and proton radiotherapy
Pascal Pommier
Yolande Lievens
Fabien Feschet
Josep M Borras
Marie Hélène Baron
Anastasiya Shtiliyanova
Madelon Pijls-Johannesma
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2010
2009
Efficacy of total lymphoid irradiation in azithromycin nonresponsive chronic allograft rejection after lung transplantation
GM Verleden
Yolande Lievens
LJ Dupont
DE Van Raemdonck
SI De Vleeschauwer
R Vos
BM Vanaudenaerde
A1
Journal Article
in
TRANSPLANTATION PROCEEDINGS
2009
Time and motion study of radiotherapy delivery: economic burden of increased quality assurance and IMRT
Evelyn Van de Werf
Yolande Lievens
Jan Verstraete
Kris Pauwels
Walter Van den Bogaert
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2009
2008
Cost-effectiveness of particle therapy: current evidence and future needs
Madelon Pijls-Johannesma
Pascal Pommier
Yolande Lievens
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2008
The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields: the EORTC-GELA lymphoma group guidelines
Theodore Girinsky
Lena Specht
Mithra Ghalibafian
Veronique Edeline
Guillaume Bonniaud
Richard Van der Maazen
Berthe Aleman
Amaury Paumier
Paul Meijnders
Yolande Lievens
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2008
2007
In regards to Allen et al. (Int J radiat oncol biol phys 2006;65: 640-645)
Yolande Lievens
Philippe Nafteux
Bianca Vanstraelen
Kristiaan Nackaerts
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2007
Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma
Berthe MP Aleman
John MM Raemaekers
Radka Tomšič
Margreet HA Baaijens
Roberto Bortolus
Marnix LM Lybeert
Richard WM Van der Maazen
Théodore Girinsky
Geertrui Demeestere
Pieternella Lugtenburg
et al.
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2007
2006
Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer
CA Dooms
Yolande Lievens
JF Vansteenkiste
A1
Journal Article
in
EUROPEAN RESPIRATORY JOURNAL
2006
Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines
Theodore Girinsky
Richard van der Maazen
Lena Specht
Berthe Aleman
Philip Poortmans
Yolande Lievens
Paul Meijnders
Mithra Ghalibafian
Jacobus Meerwaldt
Evert Noordijk
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2006
2005
CHART in lung cancer: economic evaluation and incentives for implementation
Yolande Lievens
Katrien Kesteloot
Walter Van den Bogaert
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2005
Economic consequence of local control with radiotherapy: cost analyses of internal mammary and medial supraclavicular lymph node radiotherapy in breast cancer
Yolande Lievens
Katrien Kesteloot
Walter van den Bogaert
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2005
Overview of national guidelines for infrastructure and staffing of radiotherapy: ESTRO-QUARTS: work package 1
Ben J Slotman
Brian Cottier
Sören M Bentzen
Germaine Heeren
Yolande Lievens
Walter van den Bogaert
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2005
Proton beam therapy: too expensive to become true?
Yolande Lievens
Walter Van den Bogaert
Editorial material
2005
Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884)
Berthe MP Aleman
Théodore Girinsky
Richard WM van Der Maazen
Simon Strijk
Paul Meijnders
Roberto Bortolus
Manouk JJ Olofsen-van Acht
Marnix LM Lybeert
Yolande Lievens
Houchingue Eghbali
et al.
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2005
Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project
Søren M Bentzen
Germaine Heeren
Brian Cottier
Ben Slotman
Bengt Glimelius
Yolande Lievens
Walter van den Bogaert
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2005
2004
Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience
N Lorent
P De Leyn
Yolande Lievens
E Verbeken
K Nackaerts
C Dooms
D Van Raemdonck
B Anrys
J Vansteenkiste
A1
Journal Article
in
ANNALS OF ONCOLOGY
2004
2003
Activity-based costing: a practical model for cost calculation in radiotherapy
Yolande Lievens
Walter van den Bogaert
Katrien Kesteloot
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2003
Management of unresectable non-small cell carcinoma of the lung (NSCLC)
JD Cox
T Le Chevalier
R Arriagada
H Choy
WJ Curran
M Fukuoka
P Harper
R Komaki
C Le Pechoux
Yolande Lievens
et al.
Editorial material
2003
2002
Does sucralfate reduce early side effects of pelvic radiation?: a double-blind randomized trial
Karin Stellamans
Yolande Lievens
Philippe Lambin
Danielle Van den Weyngaert
Walter Van den Bogaert
Pierre Scalliet
Liesbeth Hutsebaut
Karin Haustermans
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2002
Dose-intensified accelerated vindesine-ifosfamide-cisplatin (VIP) chemotherapy followed by high-dose accelerated hyperfractionated radiotherapy in patients with pathologically proven stage IIIB non-small cell lung cancer: a feasibility study
Dirk De Ruysscher
Yolande Lievens
Paul Van den Brande
Kris Nackaerts
Johan Vansteenkiste
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2002
Internal mammary and medial supraclavicular lymph node irradiation: the thin line between advantages and side effects
Yolande Lievens
Walter Van den Bogaert
Editorial material
2002
2001
A glance on quality assurance in EORTC study 22922 evaluating techniques for internal mammary and medial supraclavicular lymph node chain irradiation in breast cancer
Yolande Lievens
Philip Poortmans
Walter Van den Bogaert
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2001
2000
Brachytherapy with iridium-192 for bladder cancer
Hein Van Poppel
Yolande Lievens
Eric Van Limbergen
Luc Baert
A1
Journal Article
in
EUROPEAN UROLOGY
2000
Differences in palliative radiotherapy for bone metastases within Western European countries
Yolande Lievens
Katrien Kesteloot
Alex Rijnders
Gerlad Kutcher
Walter Van den Bogaert
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2000
Improved management of radiotherapy departments through accurate cost data
Katrien Kesteloot
Yolande Lievens
Emmanuel van der Schueren
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2000
Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system?
Yolande Lievens
Walter Van den Bogaert
Alex Rijnders
Gerald Kutcher
Katrien Kesteloot
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2000
1998
Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy?: a double-blind randomized trial
Yolande Lievens
Karin Haustermans
Danielle Van den Weyngaert
Walter Van den Bogaert
Pierre Scalliet
Liesbeth Hutsebaut
Jack Fowler
Philippe Lambin
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
1998
Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study
JF Vansteenkiste
PR De Leyn
GJ Deneffe
Yolande Lievens
KL Nackaerts
DE Van Raemdonck
E van der Schueren
TE Lerut
MG Demedts
A1
Journal Article
in
ANNALS OF ONCOLOGY
1998
1996
The time course of development of late side effects after irradiation of the prostate with multiple fractions per day
Yolande Lievens
L Vanuytsel
A Rijnders
H Van Poppel
E van der Schueren
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
1996